Posts Tagged ‘Vaccine’
UCSD Experts urge pregnant women? receive influenza vaccine
October 19th, 2010 | 
Author: UCSD Expert Urge Pregnant Women To Receive Influenza Vaccine
The Organization of Teratology Information Specialists (OTIS), a non-profit organization based at the University of California, San Diego with affiliates across North America, urges pregnant women to receive the influenza vaccine as soon as possible. The recommendation comes shortly after the American College of Obstetricians and Gynecologists Committee on Obstetric Practice issued new …
Read more on Medical News Today
Related Blogs
Posted in Affiliate Programs | 
Tags: Experts, Influenza, pregnant, Receive, UCSD, urge, Vaccine, Women | 
No Comments »
Vaccine Risks Report.
65% Commission-affiliates: Toxic Ingredients, Side Effects, Autism & Mercury, Know Your Rights & Choices!
Vaccine Risks Report.
Related Blogs
- Autism in the News – Wednesday, 06.02.10 « Autism Speaks Official Blog
- Delay autism – autism, behavioral and psychological development …
- Vaccine Checkpoint Evasion: Swine Flu « H1N1VaccineRisks.org
- ALERT: SWINE FLU FASCISM – IF YOUR KID AIN'T VACCINATED – THEY'RE …
- Event: Community Health Data Initiative Launched (06/02/2010 …
Reports of the DNA vaccine company Inovio Biomedical fourth quarter year ended 2009 financial results
DNA Vaccine Company Inovio Biomedical Reports Fourth Quarter and Year-Ended 2009 Financial Results
SAN DIEGO—-Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.
Read more on Business Wire via Yahoo! Finance
DNA Vaccine Company Inovio Biomedical Reports Fourth Quarter and Year-Ended 2009 Financial Results
DNA Vaccine Company Inovio Biomedical Reports Fourth Quarter and Year-Ended 2009 Financial Results
SAN DIEGO—-Inovio Biomedical Corporation today reported financial results for the quarter and year ended December 31, 2009.
Read more on Business Wire via Yahoo! Finance
Inovio Biomedical H5N1 avian influenza DNA vaccine receives approval from Korea’s first clinical trials of
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.
Read more on Business Wire via Yahoo! Finance
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
Inovio Biomedical H5N1 Avian Influenza DNA Vaccine Receives Korean Approval to Begin Clinical Trials
SAN DIEGO—-Inovio Biomedical Corporation , a leader in DNA vaccine design, development and delivery, announced today that its affiliate VGX International Inc. has received approval in Korea to begin a Phase I clinical trial in healthy volunteers for Inovio’s SynCon™ preventive DNA vaccine targeting H5N1 avian influenza.
Read more on Business Wire via Yahoo! Finance
